Welcome to our dedicated page for PETVIVO HOLDINGS WTS news (Ticker: PETVW), a resource for investors and traders seeking the latest updates and insights on PETVIVO HOLDINGS WTS stock.
PETVIVO HOLDINGS INC WTS (symbol: PETVW) is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. With a strategic approach of leveraging investments in human biomaterials and medical device industries, PETVIVO aims to bring therapeutics to pets in a capital and time-efficient manner. The company's core strategy involves in-licensing proprietary products from human medical device companies for pet use. PETVIVO HOLDINGS INC WTS is the parent company of petvivo, inc, gel-del technologies, inc, and cosmetalife corporation.
Rhea-AI Summary
PetVivo achieves milestone with sale of Spryng to over 500 veterinary clinics in 49 states
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.45%
Tags
-
Rhea-AI Summary
PetVivo Holdings, Inc. has received a notice of allowance from the USPTO for a patent application related to its biocompatible protein-based particles. The patent provides comprehensive coverage for a range of proprietary products, including the sponge-like particles used in PetVivo's signature product, Spryng™ with OsteoCushion™ Technology. PetVivo's intellectual property portfolio now consists of twenty allowed patents, with ten being United States patents.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.03%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.24%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.01%
Tags
-
News
Rhea-AI Summary
PetVivo Holdings, Inc. is approaching a milestone of selling its signature product to its 500th veterinary clinic. The company has supplied the product to over 450 clinics in 47 states, reflecting its increasing presence across the country.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.39%
Tags
-
Rhea-AI Summary
PetVivo Holdings, Inc. has rescheduled its earnings conference call for the year ending March 31, 2023 due to a technical glitch. The call will now be held on June 30, 2023 at 10:00 AM ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.23%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.8%
Tags
-
Rhea-AI Summary
PetVivo Holdings, Inc. announces Dr. Jeremy Caplin as new Research Director
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.95%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.31%
Tags
Rhea-AI Summary
PetVivo Holdings receives initial regulatory assessment for its Biomatrix Particulate Technology, paving the way for regulatory approval of various indications for human products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.52%
Tags
FAQ
What is the current stock price of PETVIVO HOLDINGS WTS (PETVW)?
The current stock price of PETVIVO HOLDINGS WTS (PETVW) is $0.0256 as of October 1, 2024.
What does PETVIVO HOLDINGS INC WTS specialize in?
PETVIVO focuses on licensing and commercializing innovative medical devices for pets, also known as pet therapeutics.
What is PETVIVO's strategic approach?
The company leverages investments in human biomaterials and medical device industries to efficiently bring therapeutics to pets.
How does PETVIVO commercialize products for pets?
PETVIVO in-licenses proprietary products from human medical device companies specifically for pet use.
What subsidiaries are under PETVIVO HOLDINGS INC?
petvivo, inc, gel-del technologies, inc, and cosmetalife are all wholly-owned subsidiaries of PETVIVO HOLDINGS INC.
What is PETVIVO's core business model?
PETVIVO's core model involves commercializing innovative medical devices for pets through strategic partnerships.
What is the significance of PETVIVO in the biomedical device industry?
PETVIVO plays a crucial role by bringing human medical advancements to the pet therapeutics sector.
How does PETVIVO ensure efficient commercialization of pet therapeutics?
PETVIVO's strategy focuses on in-licensing products from human medical device companies, streamlining the process.
What sets PETVIVO apart in the pet therapeutics market?
PETVIVO's unique approach of leveraging human medical device technology for pets sets it apart in the industry.
What are some recent achievements of PETVIVO HOLDINGS INC WTS?
PETVIVO has successfully partnered with leading human medical device companies to bring cutting-edge therapeutics to pets.
What can investors expect from PETVIVO's future projects?
Investors can anticipate further advancements in pet therapeutics through PETVIVO's ongoing projects and collaborations.
PETVIVO HOLDINGS INC WTS